Caricamento...
Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development
Most large pharmaceutical companies have downscaled or closed their clinical neuroscience research programs in response to the low clinical success rate for drugs that showed tremendous promise in animal experiments intended to model psychiatric pathophysiology. These failures have raised serious co...
Salvato in:
| Pubblicato in: | Methods Mol Biol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6895673/ https://ncbi.nlm.nih.gov/pubmed/31273690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4939-9554-7_1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|